|
| 27747837 | First-Line Treatment with Bevacizumab and Platinum Doublet Combination in Non-Squamous Non-Small Cell Lung Cancer: A Retrospective Cohort Study in US Oncology Community Practices. | Drugs Real World Outcomes | 2016 |
| 26561404 | Surgical Resection Preferences and Perceptions among Medical Oncologists Treating Liver Metastases from Colorectal Cancer. | Ann Surg Oncol | 2016 |
| 24562589 | A phase II study of capecitabine plus docetaxel in gemcitabine-pretreated metastatic pancreatic cancer patients: CapTere. | Cancer Chemother Pharmacol | 2014 |
| 23196276 | Phase II study of induction cisplatin and irinotecan followed by concurrent carboplatin, etoposide, and thoracic radiotherapy for limited-stage small-cell lung cancer, CALGB 30206. | J Thorac Oncol | 2013 |
| 23973203 | Cost effectiveness of first-line pemetrexed plus platinum compared with other regimens in the treatment of patients with nonsquamous non-small cell lung cancer in the US outpatient setting. | Lung Cancer | 2013 |
| 22197613 | Vatalanib in malignant mesothelioma: a phase II trial by the Cancer and Leukemia Group B (CALGB 30107). | Lung Cancer | 2012 |
| 22237260 | Physician preferences for management of patients with stage IIIA NSCLC: impact of bulk of nodal disease on therapy selection. | J Thorac Oncol | 2012 |
| 21529989 | A phase II trial of high dose carboplatin and paclitaxel with G-CSF and peripheral blood stem cell support followed by surgery and/or chest radiation in patients with stage III non-small cell lung cancer: CALGB 9531. | Lung Cancer | 2011 |
| 21969504 | Cisplatin, irinotecan, and bevacizumab for untreated extensive-stage small-cell lung cancer: CALGB 30306, a phase II study. | J Clin Oncol | 2011 |
| 19933904 | Phase I study of accelerated conformal radiotherapy for stage I non-small-cell lung cancer in patients with pulmonary dysfunction: CALGB 39904. | J Clin Oncol | 2010 |
| 20686428 | Chemoradiotherapy and gefitinib in stage III non-small cell lung cancer with epidermal growth factor receptor and KRAS mutation analysis: cancer and leukemia group B (CALEB) 30106, a CALGB-stratified phase II trial. | J Thorac Oncol | 2010 |
| 20521348 | Prognostic significance of mucin and p53 expression in stage IB non-small cell lung cancer: a laboratory companion study to CALGB 9633. | J Thorac Oncol | 2010 |
| 19933915 | Randomized phase III trial of vinorelbine plus cisplatin compared with observation in completely resected stage IB and II non-small-cell lung cancer: updated survival analysis of JBR-10. | J Clin Oncol | 2010 |
| 19179900 | A phase II study of carboplatin, etoposide, and exisulind in patients with extensive small cell lung cancer: CALGB 30104. | J Thorac Oncol | 2009 |
| 19632716 | Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial. | Lancet | 2009 |
| 19652624 | Treatment outcomes of different prognostic groups of patients on cancer and leukemia group B trial 39801: induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for unresectable stage III non-small cell lung cancer. | J Thorac Oncol | 2009 |
| 19561551 | Impact of the ASCO 2007 presentation of HOG Lun 01-24/USO-023 on the prescribing plans of American medical oncologists for patients with stage IIIB non-small cell lung cancer. | J Thorac Oncol | 2009 |
| 18367288 | Interruptions of once-daily thoracic radiotherapy do not correlate with outcomes in limited stage small cell lung cancer: analysis of CALGB phase III trial 9235. | Lung Cancer | 2008 |
| 18827613 | Phase II randomized study of dose-dense docetaxel and cisplatin every 2 weeks with pegfilgrastim and darbepoetin alfa with and without the chemoprotector BNP7787 in patients with advanced non-small cell lung cancer (CALGB 30303). | J Thorac Oncol | 2008 |
| 18809614 | Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups. | J Clin Oncol | 2008 |
| 18929146 | Tomorrow's cancer treatments today: the first 50 years of the Cancer and Leukemia Group B. | Semin Oncol | 2008 |
| 18978566 | Phase II trial of paclitaxel and cisplatin in patients with extensive stage small cell lung cancer: Cancer and Leukemia Group B Trial 9430. | J Thorac Oncol | 2008 |
| 18487565 | Randomized phase II trial of induction chemotherapy followed by concurrent chemotherapy and dose-escalated thoracic conformal radiotherapy (74 Gy) in stage III non-small-cell lung cancer: CALGB 30105. | J Clin Oncol | 2008 |
| 18591551 | Lessons from a time capsule: evolution, not revolution, in therapy for advanced non-small-cell lung cancer. | J Clin Oncol | 2008 |
| 18281659 | Randomized phase II Study of carboplatin and etoposide with or without the bcl-2 antisense oligonucleotide oblimersen for extensive-stage small-cell lung cancer: CALGB 30103. | J Clin Oncol | 2008 |
| 18281656 | Eicosanoid modulation in advanced lung cancer: cyclooxygenase-2 expression is a positive predictive factor for celecoxib + chemotherapy--Cancer and Leukemia Group B Trial 30203. | J Clin Oncol | 2008 |
| 18303437 | Phase II trial of weekly dose-dense paclitaxel in extensive-stage small cell lung cancer: cancer and leukemia group B study 39901. | J Thorac Oncol | 2008 |
| 18379362 | Response to the methylation inhibitor dihydro-5-azacytidine in mesothelioma is not associated with methylation of p16INK4a: results of cancer and leukemia group B 159904. | J Thorac Oncol | 2008 |
| 17065590 | Phase II trial of irinotecan/gemcitabine as second-line therapy for relapsed and refractory small-cell lung cancer: Cancer and Leukemia Group B Study 39902. | Ann Oncol | 2007 |
| 17971599 | Video-assisted thoracic surgery lobectomy: report of CALGB 39802--a prospective, multi-institution feasibility study. | J Clin Oncol | 2007 |
| 17909359 | Irinotecan-cisplatin therapy for patients with extensive-stage small cell lung cancer: use patterns among American medical oncologists 2000-2006. | J Thorac Oncol | 2007 |
| 18096059 | Phase I dose escalation study of vinorelbine and topotecan combination chemotherapy in patients with recurrent lung cancer. | BMC Cancer | 2007 |
| 18053191 | Bortezomib in combination with celecoxib in patients with advanced solid tumors: a phase I trial. | BMC Cancer | 2007 |
| 17607121 | Phase II trial of paclitaxel-topotecan-etoposide followed by consolidation chemoradiotherapy for limited-stage small cell lung cancer: CALGB 30002. | J Thorac Oncol | 2007 |
| 17607117 | Preoperative exercise Vo2 measurement for lung resection candidates: results of Cancer and Leukemia Group B Protocol 9238. | J Thorac Oncol | 2007 |
| 17311692 | A phase III study of surgical resection and paclitaxel/carboplatin chemotherapy with or without adjuvant radiation therapy for resected stage III non-small-cell lung cancer: Cancer and Leukemia Group B 9734. | Clin Lung Cancer | 2007 |
| 17404369 | Induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for regionally advanced unresectable stage III Non-small-cell lung cancer: Cancer and Leukemia Group B. | J Clin Oncol | 2007 |
| 16365181 | Similar outcomes between African American and non-African American patients with extensive-stage small-cell lung carcinoma: report from the Cancer and Leukemia Group B. | J Clin Oncol | 2006 |
| 17039491 | Nodal downstaging predicts survival following induction chemotherapy for stage IIIA (N2) non-small cell lung cancer in CALGB protocol #8935. | J Surg Oncol | 2006 |
| 16740789 | The cancer and leukemia group B respiratory committee. | Clin Cancer Res | 2006 |
| 16740598 | Abraxane, a novel Cremophor-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancer. | Ann Oncol | 2006 |
| 16401711 | How do U.S. medical oncologists learn and apply new clinical trials information from press releases in nonmedical media? A case study based on ECOG 4599. | Oncologist | 2006 |
| 15751020 | Lack of trastuzumab activity in nonsmall cell lung carcinoma with overexpression of erb-B2: 39810: a phase II trial of Cancer and Leukemia Group B. | Cancer | 2005 |
| 20871677 | Adjuvant Therapy Choices in Patients With Resected Non-Small-Cell Lung Cancer: Correlation of Doctors' Treatment Plans and Relevant Phase III Trial Data. | J Oncol Pract | 2005 |
| 16305843 | Patterns of surgical care of lung cancer patients. | Ann Thorac Surg | 2005 |
| 15829324 | Poor correspondence between clinical and pathologic staging in stage 1 non-small cell lung cancer: results from CALGB 9761, a prospective trial. | Lung Cancer | 2005 |
| 15821648 | Video-assisted wedge resection and local radiotherapy for peripheral lung cancer in high-risk patients: the Cancer and Leukemia Group B (CALGB) 9335, a phase II, multi-institutional cooperative group study. | J Thorac Cardiovasc Surg | 2005 |
| 15893012 | Irinotecan for malignant mesothelioma A phase II trial by the Cancer and Leukemia Group B. | Lung Cancer | 2005 |
| 15893009 | Phase II trial of karenitecin in patients with relapsed or refractory non-small cell lung cancer (CALGB 30004). | Lung Cancer | 2005 |
| 15923572 | Randomized phase III intergroup trial of etoposide and cisplatin with or without paclitaxel and granulocyte colony-stimulating factor in patients with extensive-stage small-cell lung cancer: Cancer and Leukemia Group B Trial 9732. | J Clin Oncol | 2005 |